NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
Back to search
Official data from USPTO
SHAREVAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SHAREVAC
ST13
US500000098697887Class
1, 5, 7, 9, 42, 44
Filing
98697887
Registration
7972673
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
10/08/2025
Trademark type
Word
Nice classes
1, 5, 7, 9, 42, 44
Filing date
08/14/2024
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Tubingen, DE
Examiner
SCHRADER,BRITTANY A
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
C. S. (pessoa física)
Representatives
Jennifer Fraser Dykema Gossett PLLC
Technical classification
Nice Classes
Class 1Class 5Class 7Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes
Class 5
Chemical preparations for medical usein particular biological macromoleculesfor therapeutic and preventive treatment of tumor diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders; Pharmaceutical preparations namelyimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of infectious diseasesautoimmune diseases and tumoursfor treatment of cancersfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; Pharmaceuticals preparations and medicines based on biological macromolecules for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment or prevention of infectious diseasesallergiesautoimmune disorders and tumour diseasesfor the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations being Nucleic acid macromolecules for in vivo or in vitro expression for human and veterinary use; Dietetic substances adapted for medical usein particular substances for food supplements; Vaccines
Class 7
Bioreactors for use in manufacturing biopharmaceuticals; Filling machinesin particular for use for filling biopharmaceutical compositions into containers; Industry roboters being industrial robots
Class 9
Scientific and laboratory apparatus for chemical synthesis; laboratory equipmentmobile laboratory equipped with scientific or laboratory apparatus for chemical synthesis; laboratory equipmentmobile laboratory equipped with scientific or laboratory apparatus for purification and analysis of synthesized compounds; laboratory equipmentmobile device for the synthesis of macromolecules; Scientific and laboratory apparatus for chemical or biological analysis and/or synthesis; laboratory equipmentmobile production station of biological macromolecules for laboratory or and for cell culturing for therapeutic use; Bioreactors for laboratory or and for cell culturing for therapeutic use
Class 42
Scientific and technological servicesscientific researchin particular for identificationtesting and characterisation of biological molecules; scientific research in the nature of pre-clinical and clinical testing of macromolecules for others; Custom synthesis of chemical compoundsin particular biological macromolecules
Class 44
Medical and veterinary servicesin particular for therapeutic and preventive treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor the treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment of metabolic disorders; Vaccination services in the nature of administering vaccines to patients
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2025
PUBO
PUBLISHED FOR OPPOSITION
08/19/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/04/2025
GNRT
NON-FINAL ACTION E-MAILED
03/04/2025
CNRT
NON-FINAL ACTION WRITTEN
03/04/2025
DOCK
ASSIGNED TO EXAMINER
02/20/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2025
NWAP
NEW APPLICATION ENTERED
08/14/2024
Continuous trademark protection
Get notified about every new filing that threatens SHAREVAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.